Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
In hyperandrogenic women, several phenotypes may be observed. This includes women with classic polycystic ovary syndrome (C-PCOS), those with ovulatory (OV) PCOS, and women with idiopathic hyperandrogenism (IHA), which occurs in women with normal ovaries. Where other causes have been excluded, we categorized 290 hyperandrogenic women who were seen consecutively for this complaint between 1993 and 2004 into these three subgroups. The aim was to compare the prevalence of obesity, insulin resistance, and dyslipidemia as well as increases in C-reactive protein and homocysteine in these different phenotypes with age-matched ovulatory controls of normal weight (n = 85) and others matched for body mass index (BMI) with women with C-PCOS (n = 42). Although BMI affected fasting serum insulin and the Quantitative Insulin-Sensitivity Check Index, these markers of insulin resistance were greatest in C-PCOS (n = 204), followed by OV-PCOS (n = 50) and then IHA (n = 33). Androgen levels were similar in OV-PCOS and IHA but were higher in C-PCOS, whereas gonadotropins were similar in all groups. Lipid abnormalities were highest in C-PCOS and OV-PCOS and were normal in IHA. C-reactive protein was elevated in C-PCOS and OV-PCOS but not IHA. Homocysteine was elevated only in C-PCOS. Overall, the prevalence of obesity (BMI > 30) was 29% in C-PCOS, 8% in OV-PCOS, and 15% in IHA and insulin resistance (Quantitative Insulin-Sensitivity Check Index < 0.33) was 68% in C-PCOS, 36% in OV-PCOS, and 26% in IHA. The prevalence of having at least one elevated cardiovascular risk marker was 45% in C-PCOS 38% in OV-PCOS and was not increased on IHA (6%). These results suggest that among hyperandrogenic women the prevalence of abnormal metabolic and cardiovascular risk parameters is greatest in C-PCOS, followed by OV-PCOS and then women with IHA. Moreover, in that in OV-PCOS and IHA, ages and weights were similar yet the prevalence of metabolic and cardiovascular risk was greater in OV-PCOS, the finding of polycystic ovaries may be a significant modifying factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 8×
“The following criteria were considered as being abnormal: obesity, BMI 30 or more; insulin resistance, QUICKI 0.330 or less (16); dyslipidemia, total cholesterol, 200 mg/dl or more and/or HDL-cholesterol, 40 mg/dl or less, and/or LDL-cholesterol, 130 mg/dl or more, and/or triglycerides, 150 mg/dl or more.”
MethodInfluentialMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · cited 1×
“It is interesting to note that, in our patients with C-PCOS, the HDL-cholesterol levels were higher and the triglyceride levels were lower than those reported in other studies of women with PCOS ( 19 ).”
ResultDepartment of Obstetrics and Gynecology
(2015) · Juntendo Medical Journal · doi:10.14789/jmj.61.322 · Cited by 365
Carmina, E., & Lobo, R. A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.041 · Cited by 294
Self-citationCarmina, E. (2003) · Human Reproduction · doi:10.1093/humrep/deg440 · Cited by 197
Self-citation
Research works printed but not linked: 1
- Zawdaki, 1992, Diagnostic criteria for polycystic ovary syndrome: toward a rationale approach, In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377
Cited by
Items 101–200 of 310
Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome
Tamimi, W., Siddiqui, I. A., Tamim, H., AlEisa, N., & Adham, M. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.06.003 · Cited by 50
Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review
Hughes, C., Elgasim, M., Layfield, R., & Atiomo, W. (2006) · Human Reproduction · doi:10.1093/humrep/del222 · Cited by 50
Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802630146 · Cited by 49
Burgers, J. A., Fong, S. L., Louwers, Y. V., Valkenburg, O., de Jong, F. H., Fauser, B. C. J. M., & Laven, J. S. E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2717 · Cited by 49
de Guevara, A. L., Otta, C. F., Crisosto, N., de Mereshian, P. S., Echiburú, B., Iraci, G. S., Pérez‐Bravo, F., & Sir‐Petermann, T. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.020 · Cited by 48
Manzoor, S., Ganie, M. A., Amin, S., Shah, Z. A., Bhat, I. A., Yousuf, S. D., Jeelani, H., Kawa, I. A., Fatima, Q., & Rashid, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-46644-4 · Cited by 46
Gong, P., Shi, B., Wang, J., Cao, P., Diao, Z., Wang, Y., Hu, Y., & Li, S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1428301 · Cited by 46
Thomann, R., Rossinelli, N., Keller, U., Tirri, B. F., De Geyter, C., Ruiz, J., Kränzlin, M., & Puder, J. J. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801893398 · Cited by 44
Huang, C.-C., Tien, Y.-J., Chen, M.-J., Chen, C.-H., Ho, H.-N., & Yang, Y.-S. (2015) · Human Reproduction · doi:10.1093/humrep/dev010 · Cited by 43
Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome?
Copp, T., Jansen, J., Doust, J., Mol, B. W., Dokras, A., & McCaffery, K. (2017) · BMJ · doi:10.1136/bmj.j3694 · Cited by 43
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.133 · Cited by 41
“Although elevated CVD and DM2 risk factors are previously reported for NIH compared with non-NIH PCOS (27–30) or non-NIH PCOS compared with controls (29, 31), this is less marked for adiposity or abdominal adiposity-matched populations (reviewed by Moran and Teede [16]).”
BackgroundVascular function in the diagnostic categories of polycystic ovary syndrome
Moran, L., Cameron, J. D., Strauss, B. J., & Teede, H. J. (2011) · Human Reproduction · doi:10.1093/humrep/der159 · Cited by 41
Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome
Soares, G. M., Vieira, C. S., Martins, W. P., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01877.x · Cited by 41
Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome
Fede, G. D., Mansueto, P., Longo, R. A., Rini, G., & Carmina, E. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.161 · Cited by 40
Self-citationCarlsen, S. M., Kjøtrød, S., Vanky, E., & Romundstad, P. (2007) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340600855946 · Cited by 40
Dietz de Loos, A. L. P., Jiskoot, G., Timman, R., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.05.008 · Cited by 39
Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS
Jarrett, B. Y., & Lujan, M. E. (2017) · Reproduction · doi:10.1530/rep-16-0385 · Cited by 39
Tratamento da infertilidade em mulheres com síndrome dos ovários policísticos
Santana, L. F., Ferriani, R. A., de Sá, M. F. S., & dos Reis, R. M. (2008) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032008000400008 · Cited by 39
Amato, M. C., Guarnotta, V., Forti, D., Donatelli, M., Dolcimascolo, S., & Giordano, C. (2013) · Human Reproduction · doi:10.1093/humrep/det105 · Cited by 38
Polycystic Ovary Syndrome in Adolescents
O'Brien, R. F., & Emans, S. J. (2008) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2007.07.007 · Cited by 38
Diamanti‐Kandarakis, E., & Christakou, C. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_4 · Cited by 38
Okoroh, E. M., Boulet, S. L., George, M. G., & Craig Hooper, W. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.10.022 · Cited by 37
Amato, M. C., Guarnotta, V., Ciresi, A., Modica, R., Pantò, F., & Giordano, C. S. D. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2669 · Cited by 37
Willis, G. R., Connolly, K. D., Ladell, K., Davies, T. S., Guschina, I. A., Ramji, D. P., Miners, K. L., Price, D. A., Clayton, A., James, P. E., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu281 · Cited by 37
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 36
Kupreeva, M., Diané, A., Lehner, R. S., Watts, R., Ghosh, M., Proctor, S. D., & Vine, D. F. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00018.2018 · Cited by 36
d'Alva, C. B., Abiven-Lepage, G., Viallon, V., Groussin, L., Dugue, M. A., Bertagna, X., & Bertherat, J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0324 · Cited by 36
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?
Rizzo, M., Berneis, K. K., Carmina, E., & Rini, G. B. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.09.014 · Cited by 35
Self-citationDiagnóstico del Síndrome de Ovario Poliquístico: nuevos fenotipos, nuevas incógnitas
Merino, P. M., Carolina Schulin-Zeuthen, P., & Ethel Codner, D. (2009) · Revista médica de Chile · doi:10.4067/s0034-98872009000800012 · Cited by 35
Carmina, E. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.001 · Cited by 34
Self-citationChiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 33
Ambroziak, U., Kępczyńska‐Nyk, A., Kuryłowicz, A., Małunowicz, E. M., Wójcicka, A., Miśkiewicz, P., & Macech, M. (2016) · Clinical Endocrinology · doi:10.1111/cen.12935 · Cited by 33
Homocysteine metabolism in polycystic ovary syndrome
Эдуардовна, Г. Е., & Kurtser, M. A. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.589927 · Cited by 31
Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome
Lai, Y., Chen, J., Li, L., Jingxia, Y., He, J., Yang, M., Jia, Y., Liu, D., Liu, H., Liao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep25934 · Cited by 31
Wang, X., Wang, H., Liu, W., Zhang, Z., Zhang, Y., Zhang, W., Chen, Z., Xia, G., & Wang, C. (2018) · Clinical Science · doi:10.1042/cs20171394 · Cited by 30
Baldani, D. P., Škrgatić, L., Šimunić, V., Zlopaša, G., Čanić, T., & Trgovčić, I. (2013) · PubMed · Cited by 30
Pelusi, C., Fanelli, F., Pariali, M., Zanotti, L., Gambineri, A., & Pasquali, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1107 · Cited by 28
Kim, Y. J., Ku, S., Jee, B. C., Suh, C. S., Kim, S. H., Choi, Y. M., Kim, J. G., & Moon, S. Y. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1401-9 · Cited by 28
Rashidi, B. H., Abediasl, J., Tehraninejad, E. S., Rahmanpour, H., & Sills, E. S. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31821bfd9c · Cited by 28
Carmina, E. (2010) · Amenorrhea · doi:10.1007/978-1-60327-864-5_4 · Cited by 26
Self-citationWang, H., Wu, T., Wu, T., Yang, G., Hu, W., Yang, M., Yang, M., Liu, D., Gu, H. F., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21852 · Cited by 26
Orio, F., Ferrarini, E., Cascella, T., Dimida, A., Palomba, S., Gianetti, E., Colao, A., Agretti, P., Vitti, P., Lombardi, G., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349210 · Cited by 25
Maharaj, S., & Amod, A. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872199 · Cited by 23
Fruzzetti, F., Ghiadoni, L., Virdis, A., Negri, F. D., Perini, D., Bucci, F., Giannarelli, C., Gadducci, A., & Taddei, S. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.03.004 · Cited by 22
Oligomenorrhoea in Exercising Women: A Polycystic Ovarian Syndrome Phenotype or Distinct Entity?
Awdishu, S., Williams, N. I., Laredo, S., & Souza, M. J. D. (2009) · Sports Medicine · doi:10.2165/11317910-000000000-00000 · Cited by 22
Sex differences in stroke across the lifespan: The role of T lymphocytes
Bravo-Alegria, J. B., McCullough, L. D., & Liu, F. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.009 · Cited by 22
Clinical implications of menstrual cycle length in oligomenorrhoeic young women
Oh, J. Y., Sung, Y., & Lee, H. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12243 · Cited by 22
Ovarian Volume in Korean Women with Polycystic Ovary Syndrome and Its Related Factors
Han, Y. S., Lee, A. R., Song, H. K., Choi, J. I., Kim, J. H., Kim, M. R., & Kim, M.-J. (2017) · Journal of Menopausal Medicine · doi:10.6118/jmm.2017.23.1.25 · Cited by 22
Ramoglu, S., Yoldemir, T., Atasayan, K., & Yavuz, D. G. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13455 · Cited by 22
Fede, G. D., Mansueto, P., Pepe, I., Rini, G. B., & Carmina, E. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.056 · Cited by 21
Self-citationIbrahim, M. K., Mostafa, M. I., Abdella, R., Marzouk, S., & El-attar, S. (2018) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2018.05.007 · Cited by 21
Does Polycystic Ovary Syndrome Itself Have Additional Effect on Apelin Levels?
Şilfeler, D. B., Gökçe, C., Kurt, R. K., Atılgan, N., Öztürk, O. H., Turhan, E., & Baloğlu, A. (2014) · Obstetrics and Gynecology International · doi:10.1155/2014/536896 · Cited by 21
Pazderska, A., Tun, T. K., Phelan, N., McGowan, A. N., Sherlock, M., Behan, L., Boran, G. P., & Gibney, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13542 · Cited by 20
[Obesity and altered arterial structure in young women with micropolycystic ovary syndrome].
Fernandes, J. B. F., Soares, G. M., Martins, W. P., de Sá, M. F. S., Ferriani, R. A., dos Reis, R. M., & Vieira, C. S. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.1590/s0100-72032009000700004 · Cited by 20
Síndrome de ovario poliquístico
Winnykamien, I., Dalibón, A., & Knoblovits, P. (2017) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/rev.hosp.ital.b.aires.v37i1.842 · Cited by 20
Talari, H. R., Azad, Z. J., Hamidian, Y., Samimi, M., Gilasi, H. R., Afshar, F. E., Ostadmohammadi, V., & Asemi, Z. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_2_18 · Cited by 19
BALDANI, D. P., SKRGATIC, L., CERNE, J. Z., OGUIC, S. K., GERSAK, B. M., & GERSAK, K. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3117 · Cited by 18
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome
Çelik, E., Türkçüoğlu, İ., Ata, B., Karaer, A., Kirici, P., Eraslan, S., Taşkapan, Ç., & Berker, B. (2016) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2016.16133 · Cited by 18
Carmina, E. (2022) · Diagnostics · doi:10.3390/diagnostics12102555 · Cited by 18
Self-citationSiddiqui, I., Tamimi, W. G., Tamim, H., AlEisa, N., & Adham, M. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1124-y · Cited by 17
Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?
Srikanthan, P., Korenman, S. G., & Davis, S. S. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.05.001 · Cited by 17
The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis
Young, H. E., & Ward, W. E. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00310-7 · Cited by 17
Fu, L., Dai, L., Li, X.-G., Zhang, K., & Bai, Y. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.10.001 · Cited by 17
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
ESPECTRO FENOTÍPICO DEL SÍNDROME DE OVARIO POLIQUÍSTICO
Rodrigo Carvajal, G., Cristian Herrera, G., & Arnaldo Porcile, J. (2010) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262010000200009 · Cited by 16
Report of the international symposium: polycystic ovary syndrome: first Latin-American consensus
Motta, A. B. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02259.x · Cited by 15
Çağlayan, A. O., Dündar, M., Tanrıverdi, F., Baysal, N. A., Ünlühızarcı, K., Özkul, Y., Borlu, M., Batukan, C., & Keleştimur, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.040 · Cited by 15
Pathophysiology of Polycystic Ovarian Syndrome
Manu, Soni, T., Victoria, V., & Prabhakar, P. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101921 · Cited by 15
Brink, H. V., Willis, A. D., Jarrett, B. Y., Lin, A., Soler, S., Best, S., Bender, E. L., Peppin, A. K., Hoeger, K. M., & Lujan, M. E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.12.136 · Cited by 15
Lin, Y.-H., Huang, S., Hsu, M.-I., Chang, Y. I., Cheng, C.-Y., Hsu, C.-S., & Tzeng, C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.09.041 · Cited by 15
Bağır, G. Ş., Bakıner, O., Bozkırlı, E., Cavlak, G., Serinsöz, H., & Ertörer, M. E. (2015) · Medical Principles and Practice · doi:10.1159/000440810 · Cited by 14
Türkçüoğlu, İ., Üstün, Y. E., Turan, F., Kalı, Z., Karabulut, A. B., Meydanli, M. M., & Kafkaslı, A. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.507291 · Cited by 14
Genotype based Risk Predictors for Polycystic Ovary Syndrome in Western Saudi Arabia
Bakhashab, S., & Ahmed, N. (2019) · Bioinformation · doi:10.6026/97320630015812 · Cited by 14
Zhou, S., Hua, R., & Quan, S. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01147-9 · Cited by 14
Need for liver evaluation in polycystic ovary syndrome
Carmina, E. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.009 · Cited by 14
Self-citationЕвгеньевна, Ч. Г., & Алексеевна, П. В. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-087 · Cited by 13
LC-MS/MS improves screening towards 21-hydroxylase deficiency
Ambroziak, U., Kępczyńska‐Nyk, A., Kuryłowicz, A., Wysłouch‐Cieszyńska, A., Małunowicz, E., Bartoszewicz, Z., Kondracka, A., Jaźwiec, R., Pawłowska, E., Szcześniak, M., et al. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.994599 · Cited by 13
Willis, G., Udiawar, M., Evans, W. D., Blundell, H. L., James, P., & Rees, A. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12834 · Cited by 13
Maier, P. S., & Spritzer, P. M. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000339317 · Cited by 12
Investigation of adrenal functions in patients with idiopathic hyperandrogenemia
Atmaca, H., Tanrıverdi, F., Ünlühızarcı, K., Bayram, F., & Keleştimur, F. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02212 · Cited by 12
Assessment of metabolic profile in a clinical setting
Pervanidou, P., Kanaka‐Gantenbein, C., & Chrousos, G. P. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241669.24923.8d · Cited by 11
Is the Risk for Cardiovascular Disease Increased in all Phenotypes of the Polycystic Ovary Syndrome?
Daskalopoulos, G. N., Karkanaki, A., Karagiannis, A. I., Mikhailidis, D. P., & Athyros, V. G. (2011) · Angiology · doi:10.1177/0003319711399571 · Cited by 10
Hara, S., Takahashi, T., Amita, M., Igarashi, H., & Kurachi, H. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000316265 · Cited by 10
Endothelial dysfunction in subfertile women with polycystic ovary syndrome
Chen, L.-H., Lin, C., Wu, H., & Chu, P. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.11.013 · Cited by 10
The Effects of Plasma Homocysteine in PCOS Women: A Review
Maharjan, P., & Hong, P. (2018) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2018.81005 · Cited by 10
Endothelial function in patients with polycystic ovary syndrome: a long-term follow-up study
Hudecova, M., Holte, J., Olovsson, M., Lind, L., & Poromaa, I. S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.048 · Cited by 9
Definition, Diagnosis, and Epidemiology of the Polycystic Ovary Syndrome
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_1 · Cited by 9
Adams, Z. H., Berbrier, D. E., Schwende, B. K., Huckins, W., Richards, C. T., Rees, A., Usselman, C. W., & Lord, R. N. (2025) · The Journal of Physiology · doi:10.1113/jp287288 · Cited by 9
Brink, H. V., Jarrett, B. Y., Pereira, N., Spandorfer, S. D., Hoeger, K., & Lujan, M. E. (2023) · Diagnostics · doi:10.3390/diagnostics13030374 · Cited by 9
Echiburú, B., de Guevara, A. L., Pereira, C., Pérez, C., Michael, P., Crisosto, N., & Sir-Petermann, T. (2014) · Revista médica de Chile · doi:10.4067/s0034-98872014000800003 · Cited by 9
Khomami, M. B., Tehrani, F. R., Hashemi, S., Mohammadi, N., Rashidi, H., & Azizi, F. (2016) · Human Reproduction · doi:10.1093/humrep/dew071 · Cited by 9
de Mendonça-Louzeiro, M. R. M. F., Annichino‐Bizzacchi, J. M., & Benetti‐Pinto, C. L. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.013 · Cited by 9
Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40
Aziz, M. Z., Wissing, M. L., Naver, K. V., Faber, J. O., & Skouby, S. O. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.879854 · Cited by 8
Velásquez, N. (2011) · Revista de Obstetricia y Ginecología de Venezuela · Cited by 8
Mishra, N., Mishra, P., Kapoor, V., Kishun, J., Kumar, A., & Singh, U. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1455_2024 · Cited by 8
Diet and exercise in the management of PCOS: Starting from the basics
Markantes, G. Κ., Tsichlia, G., & Georgopoulos, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00010-9 · Cited by 7
Polycystic Ovary Syndrome in Korean Women: Clinical Characteristics and Diagnostic Criteria
Sung, Y. (2011) · Endocrinology and Metabolism · doi:10.3803/enm.2011.26.3.203 · Cited by 7
Nutrition et infertilité féminine
Donnadieu, A. C., Pasquier, M., Meynant, C., Hugues, J., & Cédrin‐Durnerin, I. (2009) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2008.11.001 · Cited by 7
Fetal programming of polycystic ovary syndrome
Abbott, D. H., Bruns, C. M., Barnett, D. K., & Dumesic, D. A. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.016 · Cited by 7
Diamanti‐Kandarakis, E., & Panidis, D. (2006) · Women s Health · doi:10.2217/17455057.2.4.561 · Cited by 7
Metadata
- Authors
- Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A.
- Affiliations
- University of Palermo (IT)
- Columbia University (US)
- Department of Obstetrics and Gynecology (M.C.C., R.A.Lob.), Columbia University, New York, New York 10032-3784
- ORCID
- Carmina, E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05-01
- Volume
- 90
- Issue
- 5
- Pages
- 2545-2549
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2030643176
- Cited by
- 274
- References
- 21
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 1 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 2 · 2019: 8 · 2018: 6 · 2017: 10 · 2016: 16 · 2015: 11 · 2014: 15 · 2013: 15 · 2012: 16
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, hyperandrogenism, insulin resistance, obesity, dyslipidemia, cardiovascular risk factors, C-reactive protein, homocysteine, QUICKI, metabolic risk, phenotypic classification, androgen levels, gonadotropins, body mass index
- MeSH terms
- C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Insulin, Insulin Resistance, Luteinizing Hormone, Cholesterol, LDL, Phenotype, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.